Centre for Commercialization of Regenerative Medicine
Canada
Help to commercialize cell and gene therapies and regenerative medicine technologies
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|noCondition
grant_single|deadlines
- grant_single|timelineUnspecified
grant_single|financingType
Expert Advice
Researchers And Facilities
Partnering and Collaboration
Other Support
grant_single|eligibleIndustries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
grant_single|grantors
- Centre for Commercialization of Regenerative Medecine
grant_single|status
grant_card_status|open
grant_single_labels|preview
Access business services, regulatory expertise, technical services and a 40,000 square foot custom built facility for cell and gene therapy manufacturing in Toronto.
grant_single_labels|projects
grant_single|admissibleProjectsExample
$750,000
Toronto
Develop a cell therapy for chronic illnesses by using a custom-built facility in Toronto.
$475,000
Toronto
Launch a training program for gene therapy manufacturing at the Toronto facility.
$600,000
Toronto
Establish a regulatory consultation service for gene therapy startups in the Toronto facility.
$1,000,000
Toronto
Create a bioreactor to scale-up gene therapy production at the Toronto facility.
$550,000
Toronto
Design a software platform for cell therapy logistics at the Toronto facility.
$875,000
Toronto
Pilot clinical trial for new cell therapy at the Toronto manufacturing facility.
grant_single_labels|admissibility
Eligibility criteria for this grant:
- Applicants must be companies operating at the interface between academia and industry.
- Projects must involve manufacturing challenges in areas like process development, analytics, and commercial GMP-compliant manufacturing.
- Preference given to projects in cell and gene therapies, with a focus on advancing therapies towards the clinic.
grant_eligibility_criteria|who_can_apply
There are eligible types of companies for this grant. Companies in the cell and gene therapy industry with manufacturing challenges, process development needs, and GMP-compliant manufacturing requirements are suitable candidates for this grant.
- Companies in the cell and gene therapy industry
- Companies with manufacturing challenges
- Companies needing process development and analytics
- Companies requiring pre-clinical to commercial GMP-compliant manufacturing services
grant_single_labels|criteria
There are evaluation and selection criteria for this grant. The criteria include:
- Technical expertise and alignment with project goals
- Demonstrated collaborative approach to problem-solving
- Potential for successful process development and manufacturing
- Track record of delivering complex projects on time and on budget
grant_single_labels|register
- Submit a grant application through the official portal or contact CCRM directly.
- Engage in a thorough assessment with CCRM technical experts to understand your specific needs.
- Collaborate with CCRM to identify process pain points, tools, and technologies for your program.
- Execute the manufacturing plan with CCRM's team to achieve cost-effective and efficient outcomes.
Apply to this program
The CCRM Grant for Manufacturing Challenges
The CCRM Grant:
The CCRM grant is designed to support companies facing manufacturing challenges by providing access to resources, expertise, and infrastructure for the development and manufacturing of cell and gene therapies. With a team of over 55 PhDs and cutting-edge technologies, CCRM offers a collaborative and transparent approach to problem-solving, ensuring projects are completed on time and on budget.
Companies can benefit from CCRM's specialized infrastructure, including Process Development Labs and GMP Clean Rooms, which enable continuity of processes from the lab to the clean room. This grant aims to accelerate the translation of therapies into the clinic by offering comprehensive development and manufacturing plans, close collaboration with technical experts, and successful execution of complex projects.
CCRM's customer-centric approach ensures that companies receive personalized support tailored to their specific needs, allowing them to overcome process pain points and leverage the latest tools and technologies. By partnering with CCRM, companies can navigate the challenges of manufacturing cell and gene therapies more efficiently, ultimately bringing innovative therapies to patients faster.
Contact CCRM today to explore how their grant can help your company overcome manufacturing challenges and advance your therapeutic programs towards clinical success.
